Company intelligence / Profile preview

Watershed Bio

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Watershed Bio provides a cloud-based bioinformatics platform that accelerates biomedical R&D by enabling rapid analysis of large-scale genomics, transcriptomics, proteomics, and multi-modal datasets. The company does not develop its own therapeutics but empowers biologists and bioinformaticians to streamline discovery workflows. Their technology has been adopted by preclinical-stage biotech companies for target discovery and drug development support.

Therapeutic areas: OncologyRare DiseasesImmunology
Modalities: Small moleculeAntibodyGene therapymRNA-based drugsProteomics and multi-omics data analysis
Industry: Drug Discovery Services

Partnerships

SynDevRxViolet Therapeutics

Beyond the preview

Go deeper on Watershed Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Watershed Bio.

Explore the full profile